Infinity Total Liabilities Trend from 2010 to 2022

INFI
 Stock
  

USD 0.59  0.04  6.35%   

Infinity Pharmaceuti Total Liabilities is decreasing over the last several years with stable swings. Total Liabilities is predicted to flatten to about 61.7 M. During the period from 2010 to 2022 Infinity Pharmaceuti Total Liabilities regressed destribution of quarterly values had coefficient of variationof 80.23 and r-squared of  0.1. Infinity Pharmaceuti Operating Expenses is most likely to decrease significantly in the upcoming years. The last year's value of Operating Expenses was reported at 46.94 Million. The current Revenues is estimated to increase to about 1.9 M, while Consolidated Income is projected to decrease to (48.8 M).
  
Refresh
Check Infinity Pharmaceuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Infinity main balance sheet or income statement drivers, such as Gross Profit of 1.9 M, Interest Expense of 184.7 K or Operating Expenses of 64.1 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.27, PPandE Turnover of 1.29 or Receivables Turnover of 761. Infinity financial statements analysis is a perfect complement when working with Infinity Pharmaceuti Valuation or Volatility modules. It can also supplement various Infinity Pharmaceuti Technical models. Please see the analysis of Infinity Pharmaceuti Correlation against competitors.

Infinity Pharmaceuti Quarterly Total Liabilities

62.6 Million

Share

Infinity Total Liabilities Breakdown

Showing smoothed Total Liabilities of Infinity Pharmaceuti with missing and latest data points interpolated. Deferred Income Tax is recorded on Infinity Pharmaceuti balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Infinity Pharmaceuti books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.Infinity Pharmaceuti's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Infinity Pharmaceuti's overall financial position and show how it may be relating to other accounts over time.
Total Liabilities10 Years Trend
Decreasing
Stable
 Total Liabilities 
Share
      Timeline 

Infinity Total Liabilities Regression Statistics

Arithmetic Mean 70,311,628
Geometric Mean 49,453,790
Coefficient Of Variation 80.23
Mean Deviation 44,123,613
Median 61,721,167
Standard Deviation 56,408,052
Range 182,508,000
R-Value(0.31)
R-Squared 0.1
Significance 0.31
Slope(4,465,560)

Infinity Total Liabilities History

201225.5 M
201329.4 M
2014159.7 M
2015190.3 M
201643.2 M
201711.6 M
20187.8 M
201941.3 M
202062.3 M
202163.2 M
202261.7 M

About Infinity Pharmaceuti Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Infinity Pharmaceuti income statement, its balance sheet, and the statement of cash flows. Infinity Pharmaceuti investors use historical funamental indicators, such as Infinity Pharmaceuti's Total Liabilities, to determine how well the company is positioned to perform in the future. Although Infinity Pharmaceuti investors may use each financial statement separately, they are all related. The changes in Infinity Pharmaceuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infinity Pharmaceuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Infinity Pharmaceuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Infinity Pharmaceuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Total Liabilities63.2 M61.7 M
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Infinity Pharmaceuti Investors Sentiment

The influence of Infinity Pharmaceuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Infinity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Infinity Pharmaceuti Implied Volatility

    
  111.49  
Infinity Pharmaceuti's implied volatility exposes the market's sentiment of Infinity Pharmaceuti stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Infinity Pharmaceuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Infinity Pharmaceuti stock will not fluctuate a lot when Infinity Pharmaceuti's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Infinity Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Infinity Pharmaceuti's short interest history, or implied volatility extrapolated from Infinity Pharmaceuti options trading.

Current Sentiment - INFI

Infinity Pharmaceuti Investor Sentiment

Most of Macroaxis users are currently bullish on Infinity Pharmaceuti. What is your judgment towards investing in Infinity Pharmaceuti? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Infinity Pharmaceuti Correlation against competitors. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
60.1 M
Quarterly Revenue Growth YOY
0.4
Return On Assets
-0.31
Return On Equity
-1.49
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.